Research Ratings: Walgreens Boots Alliance, Inc. (WBA), TiVo Corporation (TIVO)

Robyn Valdez
February 16, 2018

Hudock Capital Group LLC boosted its stake in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator's stock worth $102,000 after buying an additional 125 shares during the last quarter. Finally, Evercore ISI began coverage on shares of Walgreens Boots Alliance in a research note on Thursday, January 4th. Truepoint Inc. now owns 8,614 shares of the pharmacy operator's stock valued at $698,000 after purchasing an additional 39 shares in the last quarter. (NYSE:GNC) [Trend Analysis], as shares plunging -8.89% to $4.51 with a share volume of 4.55 Million.

In other Walgreens Boots Alliance news, insider Stefano Pessina acquired 98,858 shares of the company's stock in a transaction that occurred on Monday, January 15th. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Several equities analysts have recently weighed in on WBA shares.

Despite "Pixel vs iPhone" Google phone sales are tiny
While that's technically double the phones Google shipped in 2016, there's a fairly important caveat to take note of. The data comes from IDC's research director Francisco Jeronimo , who said the Pixel devices "continue to grow".

Chubb Limited (CB) analysts on average have given a price target of $86.13 on CB stock. Morgan Stanley cut shares of Walgreens Boots Alliance from an "overweight" rating to an "equal weight" rating and decreased their price target for the company from $95.00 to $85.00 in a research report on Friday, October 6th. They noted that the move was a valuation call. The firm has fifty days moving average percentage of -3.71% to its latest price change.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $68.29 on Wednesday. (NASDAQ:WBA) touched its 1-Year High price of $88.00 on 02/21/17 and its 1-Year Low price of $63.82 on 10/27/17. Company fiscal year is ending in August and analysts' consensus recommendation is Outperform for WBA and estimated EPS for next quarter is 1.48. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same period in the prior year, the firm posted $1.10 EPS. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -1.10%, and looking further price to next year's EPS is 10.32%. The total volume of 871552 shares held in the session was surprisingly higher than its average volume of 6048.19 shares. This repurchase authorization permits the pharmacy operator to buy up to 5.9% of its shares through open market purchases.

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -10.91%, and has a solid year to date (YTD) performance of -5.96% which means that the stock is constantly adding to its value from the previous fiscal year end price. Investors use this ratio to decide what multiple of earnings a share is worth. This represents a $1.60 dividend on an annualized basis and a yield of 2.34%. The ex-dividend date is Wednesday, February 14th.

Justice Department's No. 3 official to resign
Her job as associate deputy AG entailed overseeing the civil rights and antitrust divisions of the DOJ. If Rosenstein had been fired or quit, oversight of Mueller's investigation would have fallen to Brand.

Evercore analysts said Walgreens could fund all or a majority of the transaction via debt, likely making the financial returns notably attractive. If you are accessing this report on another domain, it was illegally copied and republished in violation of U.S. and global trademark & copyright legislation.

AmerisourceBergen shares rose 15.7 percent in after-hours trading and shares of Walgreens, which has around 13,000 drugstores worldwide, mostly in the United States, were unchanged.

GNC Holdings Inc. (GNC) reported on Tuesday that it a loss of $209.8 million in its fourth quarter.

Yu Darvish agrees to 6-year, $126M deal with Cubs
Despite today's news, Cubs fans almost thought they had signed the Japanese pitcher a little over a month ago. The deal will be worth $126 million, with incentives making it worth up to $150 million, Rosenthal reported.

Analysts said any deal would not be a surprise, but it might cost Walgreens opportunities down the line as the company tries to keep pace with rival CVS Health.

Other reports by Info About Network

Discuss This Article